Low Dose Naltrexone (LDN) is being used as a regulator of the immune system, providing relief to patients with autoimmune diseases, and central nervous system disorders.  Whilst it is not licensed by the FDA specifically for these conditions, physicians are permitted to prescribe LDN ‘off-label’ for any use they think is appropriate.

The apparently diverse conditions in which LDN appears to have a therapeutic effect are united by their ability to benefit from increased levels of endorphins (naturally occurring opioids – specifically OGF).

In the interests of promoting further research into different uses of LDN, we encourage LDN users who are willing to be identified to post their experiences with LDN here. Examples of the successful use of LDN, supported by studies as well as reported by patients to date, include the following conditions:

> Published Studies

• - Crohn’s Diseases
• - Multiple Sclerosis
• - Fibromyalgia

> Patient-Reported

• - Ankolysing Spondilitis
• - Epstein-Barr Syndrome
• - Hepatitis C
• - Lung Cancer
• - Rheumatoid Arthritis
• - Systemic Lupus Erythematosus (SLE)
• - Parkinson's Disease
• - Ulcerative Colitis